Prevalence of subclinical hypothyroidism and biomarkers of cardiovascular risk in patients of the General Hospital of Riobamba
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The publication is free and its contents are distributed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND 4.0). The rights of the works published in this journal are property of the author and they are free to distribute and disseminate the same sources as long as he correctly cites the font of publication, these acts are not for commercial purposes and no derivative works are generated.
Main Article Content
Abstract
El hipotiroidismo subclínico (SH) se define bioquímicamente por una elevación en la concentración sérica de la hormona TSH con niveles normales de T4 libre. El objetivo de este estudio fue determinar la prevalencia de HS en pacientes que acuden a la consulta de medicina interna del Hospital General IESS de Riobamba. Asimismo, analizar la correlación entre parámetros hormonales y determinados marcadores bioquímicos asociados a un mayor riesgo cardiovascular. Se realizó un diseño descriptivo, observacional, no experimental de corte transversal, que abarcó el período de enero de 2019 a septiembre de 2021. Se diagnosticaron 245 pacientes con HS, lo que representó el 10,58 % del universo poblacional estudiado, el 61,2 % correspondió al sexo femenino, mientras que el 38,8 % eran hombres. El mayor número de casos (59,61 %) se observó en el grupo etario de mayores de 65 años, distribuidos de la siguiente manera: (22,86 % hombres y 36,75 % mujeres),
References
Andersson, C., Nayor, M., Tsao, C. W., Levy, D., & Vasan, R. S. (2021). Framingham Heart Study: JACC Focus Seminar, 1/8. Journal of the American College of Cardiology, 77(21), 2680–2692. https://doi.org/10.1016/j.jacc.2021.01.059
Biondi, B., Cappola, A. R., & Cooper, D. S. (2019). Subclinical Hypothyroidism: A Review. JAMA, 322(2), 153–160. https://doi.org/10.1001/jama.2019.9052
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002). Effects of subclinical thyroid dysfunction on the heart. Annals of internal medicine, 137(11), 904–914. https://doi.org/10.7326/0003-4819-137-11-200212030-00011
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000). The Colorado thyroid disease prevalence study. Archives of internal medicine, 160(4), 526–534. https://doi.org/10.1001/archinte.160.4.526.
Delitala, A. P., Scuteri, A., Maioli, M., Mangatia, P., Vilardi, L., & Erre, G. L. (2019). Subclinical hypothyroidism and cardiovascular risk factors. Minerva medica, 110(6), 530–545. https://doi.org/10.23736/S0026-4806.19.06292-X
Hak, A. E., Pols, H. A., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. (2000). Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of internal medicine, 132(4), 270–278. https://doi.org/10.7326/0003-4819-132-4-200002150-00004
Imaizumi, M., Akahoshi, M., Ichimaru, S., Nakashima, E., Hida, A., Soda, M., Usa, T., Ashizawa, K., Yokoyama, N., Maeda, R., Nagataki, S., & Eguchi, K. (2004). Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. The Journal of clinical endocrinology and metabolism, 89(7), 3365–3370. https://doi.org/10.1210/jc.2003-031089
Kahaly G. J. (2000). Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid : official journal of the American Thyroid Association, 10(8), 665–679. https://doi.org/10.1089/10507250050137743
Kilic, I. D., Tanriverdi, H., Fenkci, S., Akin, F., Uslu, S., & Kaftan, A. (2013). Noninvasive indicators of atherosclerosis in subclinical hypothyroidism. Indian journal of endocrinology and metabolism, 17(2), 271–275. https://doi.org/10.4103/2230-8210.109708
Manolis, A. A., Manolis, T. A., Melita, H., & Manolis, A. S. (2020). Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?. Trends in cardiovascular medicine, 30(2), 57–69. https://doi.org/10.1016/j.tcm.2019.02.011
Manolis, A. A., Manolis, T. A., Melita, H., & Manolis, A. S. (2020). Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?. Trends in cardiovascular medicine, 30(2), 57–69. https://doi.org/10.1016/j.tcm.2019.02.011
Mizuma, H., Murakami, M., & Mori, M. (2001). Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circulation research, 88(3), 313–318. https://doi.org/10.1161/01.res.88.3.313.
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008). Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of internal medicine, 148(11), 832–845. https://doi.org/10.7326/0003-4819-148-11-200806030-00225
Pearce, S. H., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J. L. (2013). 2013 ETA Guideline: Management of Subclinical Hypothyroidism. European thyroid journal, 2(4), 215–228. https://doi.org/10.1159/000356507
Rodríguez Ramos, Jorge Félix, Boffill Corrales, Acela María, & Rodríguez Soria, Alberto. (2016). Factores de riesgo de las enfermedades tiroideas. Hospital del Seguro Social Ambato. Revista de Ciencias Médicas de
Pinar del Río, 20(5), 113-128. Recuperado en 13 de julio de 2022, de http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942016000500014&lng=es&tlng=es.
Saif, A., Mousa, S., Assem, M., Tharwat, N., & Abdelhamid, A. (2018). Endothelial dysfunction and the risk of atherosclerosis in overt and subclinical hypothyroidism. Endocrine connections, 7(10), 1075–1080. https://doi.org/10.1530/EC-18-0194
Schultz, M., Kistorp, C., Raymond, I., Dimsits, J., Tuxen, C., Hildebrandt, P., & Faber, J. (2011). Cardiovascular events in thyroid disease: a population based, prospective study. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 43(9), 653–659. https://doi.org/10.1055/s-0031-1283162
Tene, D., Urdaneta, G., Robalino, J., & Pedreañez, A. (2021). Óxido nítrico y fibrinógeno en pacientes con hipotiroidismo subclínico y su posible relación con el daño cardiovascular. Revista Internacional de Ciencias Médicas y Quirúrgicas, 8 (4), 1–12. https://doi.org/10.32457/ijmss.v8i4.173
Tene, D; Muñóz, N; Mosquera, J; Pedreáñez, A. (2021). Incremento de la proteína C reactiva ultrasensible en pacientes con hipotiroidismo subclínico y su posible relación con el desarrollo de daño cardiovascular. Rev. chil. endocrinol. diabetes. 14(2): 59-64.
Vanderpump, M. P., Tunbridge, W. M., French, J. M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Rodgers, H., Tunbridge, F., & Young, E. T. (1996). The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid : official journal of the American Thyroid Association, 6(3), 155–160. https://doi.org/10.1089/thy.1996.6.155
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O'Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005). Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of internal medicine, 165(21), 2467–2472. https://doi.org/10.1001/archinte.165.21.2467
Zamrazil V. (2015). Subklinické tyreopatie [Subclinical thyroid disease]. Vnitrni lekarstvi, 61(10), 873–876.